Stamcellebehandling af knæartrose

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Stamcellebehandling af knæartrose. / Berg, Lise Charlotte.

In: Ugeskrift for Laeger, Vol. 182, V05200333, 2020.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Berg, LC 2020, 'Stamcellebehandling af knæartrose', Ugeskrift for Laeger, vol. 182, V05200333. <https://ugeskriftet.dk/files/scientific_article_files/2020-10/v05200333_web.pdf>

APA

Berg, L. C. (2020). Stamcellebehandling af knæartrose. Ugeskrift for Laeger, 182, [V05200333]. https://ugeskriftet.dk/files/scientific_article_files/2020-10/v05200333_web.pdf

Vancouver

Berg LC. Stamcellebehandling af knæartrose. Ugeskrift for Laeger. 2020;182. V05200333.

Author

Berg, Lise Charlotte. / Stamcellebehandling af knæartrose. In: Ugeskrift for Laeger. 2020 ; Vol. 182.

Bibtex

@article{d83c43da9be14ac98a1d3db44d1c8cb1,
title = "Stamcellebehandling af kn{\ae}artrose",
abstract = "Stem cell therapy is a promising new treatment option for a range of conditions including osteoarthritis (OA). Recent clinical studies in patients with knee OA have shown that stem cell therapy may improve pain scores and joint mobility for up to 12-24 months. However, the studies vary in study design and quality making comparisons difficult, and there is a lack of controls. The mode-of-action of stem cells in the joint is still largely unknown. A large number of clinical studies are underway and will increase our understanding of the efficacy and function of stem cells in OA.",
author = "Berg, {Lise Charlotte}",
year = "2020",
language = "Dansk",
volume = "182",
journal = "Ugeskrift for Laeger",
issn = "0041-5782",
publisher = "Almindelige Danske Laegeforening",

}

RIS

TY - JOUR

T1 - Stamcellebehandling af knæartrose

AU - Berg, Lise Charlotte

PY - 2020

Y1 - 2020

N2 - Stem cell therapy is a promising new treatment option for a range of conditions including osteoarthritis (OA). Recent clinical studies in patients with knee OA have shown that stem cell therapy may improve pain scores and joint mobility for up to 12-24 months. However, the studies vary in study design and quality making comparisons difficult, and there is a lack of controls. The mode-of-action of stem cells in the joint is still largely unknown. A large number of clinical studies are underway and will increase our understanding of the efficacy and function of stem cells in OA.

AB - Stem cell therapy is a promising new treatment option for a range of conditions including osteoarthritis (OA). Recent clinical studies in patients with knee OA have shown that stem cell therapy may improve pain scores and joint mobility for up to 12-24 months. However, the studies vary in study design and quality making comparisons difficult, and there is a lack of controls. The mode-of-action of stem cells in the joint is still largely unknown. A large number of clinical studies are underway and will increase our understanding of the efficacy and function of stem cells in OA.

M3 - Tidsskriftartikel

VL - 182

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

SN - 0041-5782

M1 - V05200333

ER -

ID: 260037747